Curasight Investor Relations Material
Latest events
Q3 2023 [DK]
Curasight
Access the full event backlog
Slides, Transcripts, and Reports from over 8,000 public companies
Curasight is a clinical stage biopharmaceutical company dedicated to developing uPAR Theranostics for the early detection, diagnosis and treatment of cancer. The company's mission is to make a global impact by harnessing imaging technology that improves diagnosis and correlates to improved long-term patient outcome.
Latest articles
NIBE: Creating Millionaires and a Greener Future
NIBE, just like IKEA, was founded in a rural part of Sweden called Småland. The company offers a wide range of pumps, wood stoves, and solar panels.
6 Dec 2023
The Story of Jensen Huang and Nvidia
When looking at NVIDIA’s Jensen Huang today, it is easy to stereotype him as your archetypical big tech CEO. He doesn’t wear suits like a Wall Street Chairman, instead opting to wear his now-iconic leather jackets and casual polo shirts.
6 Dec 2023
Neglect of Probability: A Hidden Risk in Decision Making
The concept of "probability" should take center stage in our decision-making processes.
4 Dec 2023
Ticker symbol
CURAS
Country
🇩🇰 Denmark